A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study. [electronic resource]
Producer: 20150623Description: 289 p. digitalISSN:- 1471-2334
- Adult
- Aged
- Aged, 80 and over
- Aminoglycosides -- adverse effects
- Anti-Bacterial Agents -- therapeutic use
- Bacteremia -- drug therapy
- Catheter-Related Infections -- complications
- Double-Blind Method
- Female
- Humans
- Lipoglycopeptides
- Male
- Methicillin-Resistant Staphylococcus aureus -- drug effects
- Middle Aged
- Penicillins -- therapeutic use
- Staphylococcal Infections -- drug therapy
- Staphylococcus aureus -- drug effects
- Treatment Outcome
- Vancomycin -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.